VINORELBINE Drug Patent Profile

When do Vinorelbine patents expire, and when can generic versions of Vinorelbine launch?

Vinorelbine is a drug marketed by Actavis Totowa, Dr Reddys, Ebewe Pharma, Fresenius Kabi Usa, Hikma, Hospira, Jiangsu Hansoh Pharm, Novast Labs, Rising, and Teva Pharms Usa. and is included in eleven NDAs.

The generic ingredient in VINORELBINE is vinorelbine tartrate. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Vinorelbine

A generic version of VINORELBINE was approved as vinorelbine tartrate by HIKMA on June 10^th, 2003.

Summary for VINORELBINE

US Patents:	0
Applicants:	10
NDAs:	11
DailyMed Link:	VINORELBINE at DailyMed

US Patents and Regulatory Information for VINORELBINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Totowa	VINORELBINE TARTRATE	vinorelbine tartrate	INJECTABLE;INJECTION	078011-001	Jul 22, 2009	AP	RX	No	No
Hospira	VINORELBINE TARTRATE	vinorelbine tartrate	INJECTABLE;INJECTION	076827-001	Jun 2, 2005		DISCN	No	No
Fresenius Kabi Usa	VINORELBINE TARTRATE	vinorelbine tartrate	INJECTABLE;INJECTION	076849-001	Apr 18, 2005		DISCN	No	No
Jiangsu Hansoh Pharm	VINORELBINE TARTRATE	vinorelbine tartrate	INJECTABLE;INJECTION	091106-001	Sep 26, 2012	AP	RX	No	Yes
Dr Reddys	VINORELBINE TARTRATE	vinorelbine tartrate	INJECTABLE;INJECTION	202017-001	Sep 12, 2013	AP	RX	No	No
Ebewe Pharma	VINORELBINE TARTRATE	vinorelbine tartrate	INJECTABLE;INJECTION	078408-001	Feb 13, 2008		DISCN	No	No
Hikma	VINORELBINE TARTRATE	vinorelbine tartrate	INJECTABLE;INJECTION	076461-001	Dec 11, 2003	AP	RX	No	No

DrugChatter Q&A for VINORELBINE

How does Vinorelbine differ from Vincristine?